HEADER DE NOVO PROTEIN 11-SEP-01 1JY9 TITLE MINIMIZED AVERAGE STRUCTURE OF DP-TT2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DP-TT2; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS SYNTHESIZED BY SOLID PHASE PEPTIDE SOURCE 4 SYNTHESIS. KEYWDS BETA-HAIRPIN, DE NOVO PROTEIN EXPDTA SOLUTION NMR AUTHOR H.E.STANGER,F.A.SYUD,J.F.ESPINOSA,I.GIRIAT,T.MUIR,S.H.GELLMAN REVDAT 4 23-FEB-22 1JY9 1 REMARK LINK REVDAT 3 24-FEB-09 1JY9 1 VERSN REVDAT 2 17-OCT-01 1JY9 1 JRNL REVDAT 1 19-SEP-01 1JY9 0 JRNL AUTH H.E.STANGER,F.A.SYUD,J.F.ESPINOSA,I.GIRIAT,T.MUIR, JRNL AUTH 2 S.H.GELLMAN JRNL TITL LENGTH-DEPENDENT STABILITY AND STRAND LENGTH LIMITS IN JRNL TITL 2 ANTIPARALLEL BETA -SHEET SECONDARY STRUCTURE. JRNL REF PROC.NATL.ACAD.SCI.USA V. 98 12015 2001 JRNL REFN ISSN 0027-8424 JRNL PMID 11593011 JRNL DOI 10.1073/PNAS.211536998 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DIANA 1.5, DIANA 1.5 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER, WUTHRICH (DIANA), GUNTERT, REMARK 3 MUMENTHALER, WUTHRICH (DIANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JY9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-SEP-01. REMARK 100 THE DEPOSITION ID IS D_1000014325. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 277 REMARK 210 PH : 3.8 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM PEPTIDE REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NOE INTENSITIES WERE REMARK 210 QUALITATIVELY ASSIGNED TO BE REMARK 210 STRONG, MEDIUM, WEAK OR VERY REMARK 210 WEAK, AND ASSIGNED CONSTRAINTS REMARK 210 OF 3, 4, 5, AND 6 RESPECTIVELY; REMARK 210 A TOTAL OF 32 RESTRAINTS WERE REMARK 210 USED FOR DP-TT2. RESTRAINTS WERE REMARK 210 CHECKED USING "DISTANCE CHECK" REMARK 210 FUNCTION WITHIN DYANA WHICH REMARK 210 SHOWED THERE WERE NO "LONELY" OR REMARK 210 POSSIBLY MISASSIGNED NOES WHICH REMARK 210 COULD UNDULY INFLUENCE THE FINAL REMARK 210 CONFORMATION. DYANA WAS USED TO REMARK 210 GENERATE 500 RANDOM STRUCTURES, REMARK 210 WHICH WERE SUBSEQUENTLY REMARK 210 ANNEALED. THE BEST 10 STRUCTURES REMARK 210 (FEWEST RESTRAINT VIOLATIONS) REMARK 210 WERE SELECTED. THIS ENTRY REMARK 210 CONTAINS THE MINIMIZED AVERAGE REMARK 210 STRUCTURE. REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: ROESY TO CHECK FOR SPIN DIFFUSION. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 2 -43.06 -174.13 REMARK 500 LYS A 12 -91.40 -160.13 REMARK 500 LYS A 13 -177.41 179.80 REMARK 500 ILE A 14 147.94 -176.36 REMARK 500 THR A 17 37.29 -153.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE 12 IN THE PEPTIDE IS ORNITHINE. REMARK 999 FOR MODELLING, LYSINE WAS USED IN PLACE REMARK 999 OF ORNITHINE FOR EASE OF CALCULATION. DBREF 1JY9 A 1 20 PDB 1JY9 1JY9 1 20 SEQRES 1 A 20 THR THR THR THR ARG TYR VAL GLU VAL DPR GLY LYS LYS SEQRES 2 A 20 ILE LEU GLN THR THR THR THR MODRES 1JY9 DPR A 10 PRO D-PROLINE HET DPR A 10 14 HETNAM DPR D-PROLINE FORMUL 1 DPR C5 H9 N O2 SHEET 1 A 2 TYR A 6 VAL A 7 0 SHEET 2 A 2 ILE A 14 LEU A 15 -1 O ILE A 14 N VAL A 7 LINK C VAL A 9 N DPR A 10 1555 1555 1.36 LINK C DPR A 10 N GLY A 11 1555 1555 1.32 CRYST1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000